Gabriel Chow - Concepedia

Author

Gabriel Chow

Nottingham University Hospitals NHS Trust ORCID

Also Known As

Chow, G, G Chow, G. Chow, Gabriel C.S. Chow, Gabriel Chow, M Vennegues

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Nottingham University Hospitals NHS Trust University College London Queen's Medical Centre Great Ormond Street Hospital University of Nottingham

About

Gabriel Chow is an author at Nottingham University Hospitals NHS Trust specializing in medicine, neurology, and cerebral blood flow.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	504
2	Health Sciences	1	1	161
3	Public Health	1	1	39
4	Anesthesia	1	1	18
5	Biostatistics	1	1	202

Gabriel Chow

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Genotype–phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations Fatemeh Geranmayeh, Emma Clement, Lucy Feng, Neuromuscular Disorders Genetic DisorderGeneticsGenotype–phenotype CorrelationMuscular Dystrophy PatientsBiostatistics	2010	202
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial Anthony G Marson, Girvan Burnside, Richard Appleton, The Lancet	2021	202
Neurological Manifestations of Influenza Infection in Children and Adults: Results of a National British Surveillance Study Anu Goenka, Benedict Michael, Elizabeth Ledger, Clinical Infectious Diseases	2013	183
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial Anthony G Marson, Girvan Burnside, Richard Appleton, The Lancet	2021	183
Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial Finbar O’Callaghan, Stuart W. Edwards, Fabienne Dietrich Alber, The Lancet Child & Adolescent Health Pain DisordersHormonal TreatmentPediatricsInfantile SpasmsPain Management	2018	161
Clinical features, course, and outcomes of a UK cohort of pediatric moyamoya Sara Tho-Calvi, Dominic Thompson, Dawn E. Saunders, Neurology	2018	114
<i>SEPN1</i> -related myopathies Mariacristina Scoto, Sebahattin Çirak, R. Mein, Neurology	2011	82
Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain Clare V. Logan, Judith Cossins, Pedro M. Rodríguez Cruz, The American Journal of Human Genetics	2015	78
The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations Pedro M. Rodríguez Cruz, Judith Cossins, Eduardo de Paula Estephan, Brain	2019	50
Longitudinal analysis of the neurological features of ataxia‐telangiectasia Thomas J. Jackson, Gabriel Chow, Mohnish Suri, Developmental Medicine & Child Neurology	2016	46

Page 1